{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T23:33:28Z","timestamp":1763768008477,"version":"3.41.2"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:00:00Z","timestamp":1721001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Mucopolysaccharidosis type I (MPS I) is an autosomal recessive lysosomal storage disorder characterized by deficient or absent <jats:italic>\u03b1<\/jats:italic>-L-iduronidase (IDUA) enzyme activity due to pathogenic variants in the <jats:italic>IDUA<\/jats:italic> gene. Early treatment with hematopoietic stem cell transplantation and\/or enzyme replacement therapy is associated with improved outcomes in this progressive multisystem disease. The diagnosis is usually delayed due to late presentation and non-specific symptoms, which result in high morbidity and mortality. The incidence of MPS I is unknown in Kuwait. This pilot study was undertaken to screen MPS I in all Kuwaiti neonates born at Farwaniya Hospital (FH), a major center in Kuwait, over 12\u2005months. This study examined the incidence of MPS I for inclusion in the national newborn screening (NBS) to enable its early detection and adequate treatment. All Kuwaiti neonates born at FH between December 2021 and December 2022 were screened for MPS I. The screening consisted of determining IDUA enzyme activity in dried blood spot-derived samples using tandem mass spectrometry. A follow-up genetic analysis of the <jats:italic>IDUA<\/jats:italic> gene has been planned to screen the cases with diminished IDUA enzyme activity as second-tier testing. A total of 618 newborns, including 331 (54%) boys and 287 (46%) girls, were screened. Of them, 20 had deficient IDUA enzyme activity but showed negative genetic testing. However, we have diagnosed one additional female infant with MPS I who belonged to FH, but the parents chose to deliver in a private hospital. The molecular genetic study revealed the presence of a previously reported pathogenic nonsense variant in the <jats:italic>IDUA<\/jats:italic> c.1882C&amp;gt;T, which is associated with severe phenotype. That being included, MPS I is estimated to be approximately 0.2% of all screened cases in Kuwait. Our study is the first to evaluate the incidence of MPS I in Kuwait. Given the single center, small number of screened infants, and the short study duration thus far, it is premature to calculate the incidence. It is anticipated that as the study continues, we would be able to estimate the incidence in our population correctly. Screening newborns in all maternity hospitals in Kuwait is necessary to calculate the actual incidence of this severe disorder. Still, our preliminary data support the inclusion of MPS I in national NBS program to allow early initiation of treatment and thus improve disease outcome.<\/jats:p>","DOI":"10.3389\/fped.2024.1376053","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T05:01:39Z","timestamp":1721019699000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Enzymatic testing for mucopolysaccharidosis type I in Kuwaiti newborns: a preliminary study toward newborn screening"],"prefix":"10.3389","volume":"12","author":[{"given":"Hind","family":"Alsharhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Z.","family":"Haider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bann","family":"Qadoura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariam","family":"Ayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gursev S.","family":"Dhaunsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hessa","family":"Alkandari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,15]]},"reference":[{"year":"","author":"Clarke","key":"B1"},{"year":"","key":"B2"},{"year":"","key":"B3"},{"key":"B4","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s10038-020-0744-8","article-title":"Newborn screening of mucopolysaccharidoses: past, present, and future","volume":"65","author":"Arunkumar","year":"2020","journal-title":"J Hum Genet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/ajmg.a.61930","article-title":"Mucopolysaccharidosis type I newborn screening: importance of second tier testing for ethnically diverse populations","volume":"185","author":"Bosfield","year":"2021","journal-title":"Am J Med Genet A"},{"key":"B6","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1590\/S1415-47572010005000093","article-title":"Mucopolysaccharidosis I, II, and VI: brief review and guidelines for treatment","volume":"33","author":"Giugliani","year":"2010","journal-title":"Genet Mol Biol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1515\/jpem-2019-0188","article-title":"Mapping of IDUA gene variants in Pakistani patients with mucopolysaccharidosis type 1","volume":"32","author":"Zahoor","year":"2019","journal-title":"J Pediatr Endocrinol Metab"},{"volume-title":"Newborn Screening for Mucopolysaccharidosis Type 1 (MPS I): A Systematic Review of Evidence Report of Final Findings Final Version 1.1 the Condition Review Workgroup. Public Health System Impact-Task Leader","year":"2015","author":"Kemper","key":"B8"},{"key":"B9","doi-asserted-by":"publisher","first-page":"100563","DOI":"10.1016\/j.ymgmr.2019.100563","article-title":"Newborn screening for mucopolysaccharidoses: measurement of glycosaminoglycans by LC-MS\/MS","volume":"22","author":"Stapleton","year":"2020","journal-title":"Mol Genet Metab Rep"},{"key":"B10","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1136\/bmj.39002.350405.80","article-title":"Genetic disease in the Arab world","volume":"333","author":"Bayoumi","year":"2006","journal-title":"Br Med J"},{"key":"B11","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1136\/bmj.38982.704931.AE","article-title":"Genetic disorders in the Arab world","volume":"333","author":"Al-Gazali","year":"2006","journal-title":"Br Med J"},{"key":"B12","first-page":"169","article-title":"Incidence of mucopolysaccharidoses in Tunisia","volume":"87","author":"Turkia","year":"2009","journal-title":"Tunis Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e28619","DOI":"10.2196\/28619","article-title":"Mucopolysaccharidosis type I disease prevalence among patients with idiopathic short stature in Saudi Arabia: protocol for a multicenter cross-sectional study","volume":"10","author":"Alsafadi","year":"2021","journal-title":"JMIR Res Protoc"},{"key":"B14","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13023-015-0344-4","article-title":"Early treatment with laronidase improves clinical outcomes in patients with attenuated MPS I: a retrospective case series analysis of nine sibships","volume":"10","author":"Al-Sannaa","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ymgme.2012.09.004","article-title":"Long-term efficacy of hematopoietic stem cell transplantation on brain involvement in patients with mucopolysaccharidosis type II: a nationwide survey in Japan","volume":"107","author":"Tanaka","year":"2012","journal-title":"Mol Genet Metab"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1182\/blood-2014-11-608075","article-title":"Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study","volume":"125","author":"Aldenhoven","year":"2015","journal-title":"Blood"},{"key":"B17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1750-1172-6-55","article-title":"Enzyme replacement therapy and\/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure","volume":"6","author":"de Ru","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jpeds.2016.08.033","article-title":"Outcomes of long-term treatment with laronidase in patients with mucopolysaccharidosis type I","volume":"178","author":"Laraway","year":"2016","journal-title":"J Pediatr"},{"key":"B19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/ijns6040091","article-title":"Newborn screening for mucopolysaccharidosis I: moving forward learning from experience","volume":"6","author":"Clarke","year":"2020","journal-title":"Int J Neonatal Screen"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-019-0665-3","article-title":"Newborn screening in mucopolysaccharidoses","volume":"44","author":"Donati","year":"2018","journal-title":"Ital J Pediatr"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/ijns4030024","article-title":"Current state of the art of newborn screening for lysosomal storage disorders","volume":"4","author":"Millington","year":"2018","journal-title":"Int J Neonatal Screen"},{"year":"","key":"B22"},{"key":"B23","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/ijns7030056","article-title":"Early diagnosis of classic homocystinuria in Kuwait through newborn screening: a 6-year experience","volume":"7","author":"Alsharhan","year":"2021","journal-title":"Int J Neonatal Screen"},{"key":"B24","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.jpeds.2013.01.031","article-title":"Identification of infants at risk for developing Fabry, Pompe, or mucopolysaccharidosis-I from newborn blood spots by tandem mass spectrometry","volume":"163","author":"Scott","year":"2013","journal-title":"J Pediatr"},{"key":"B25","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ymgme.2020.04.001","article-title":"\u03b1-mannosidosis\u2014an underdiagnosed lysosomal storage disease in individuals with an \u201cMPS-like\u201d phenotype","volume":"130","author":"Wiesinger","year":"2020","journal-title":"Mol Genet Metab"},{"key":"B26","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s10545-017-0098-3","article-title":"Newborn screening for lysosomal storage disorders by tandem mass spectrometry in North East Italy","volume":"41","author":"Burlina","year":"2018","journal-title":"J Inherit Metab Dis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ymgme.2016.05.015","article-title":"Pilot study of newborn screening for six lysosomal storage diseases using tandem mass spectrometry","volume":"118","author":"Elliott","year":"2016","journal-title":"Mol Genet Metab"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.3390\/diagnostics11091583","article-title":"Nationwide newborn screening program for mucopolysaccharidoses in Taiwan and an update of the \u201cgold standard\u201d criteria required to make a confirmatory diagnosis","volume":"11","author":"Chuang","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1373\/clinchem.2016.269167","article-title":"Multiplex tandem mass spectrometry enzymatic activity assay for newborn screening of the mucopolysaccharidoses and -type 2 neuronal ceroid lipoduscinosis","volume":"63","author":"Liu","year":"2017","journal-title":"Clin Chem"},{"key":"B30","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3390\/ijms21010114","article-title":"Identification and functional characterization of IDS gene mutations underlying Taiwanese Hunter syndrome (mucopolysaccharidosis type II)","volume":"21","author":"Lin","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B31","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"year":"","key":"B32"},{"key":"B33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/8904_2014_308","article-title":"Dried blood spots allow targeted screening to diagnose mucopolysaccharidosis and mucolipidosis","volume":"15","author":"Cobos","year":"2015","journal-title":"JIMD Rep"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1002\/humu.23301","article-title":"IDUA Mutational profile and genotype-phenotype relationships in UK patients with mucopolysaccharidosis type I","volume":"38","author":"Ghosh","year":"2017","journal-title":"Hum Mutat"},{"key":"B35","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/cge.13583","article-title":"Genotype-phenotype relationships in mucopolysaccharidosis type I (MPS I): insights from the international MPS I registry","volume":"96","author":"Clarke","year":"2019","journal-title":"Clin Genet"},{"key":"B36","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1746-1596-6-39","article-title":"Molecular analysis of mucopolysaccharidosis type I in Tunisia: identification of novel mutation and eight novel polymorphisms","volume":"6","author":"Chkioua","year":"2011","journal-title":"Diagn Pathol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1097\/00125817-200211000-00004","article-title":"Diversity of mutations and distribution of single nucleotide polymorphic alleles in the human alpha-L-iduronidase (IDUA) gene","volume":"4","author":"Li","year":"2002","journal-title":"Genet Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s004390100606","article-title":"Mutational analysis of 85 mucopolysaccharidosis type I families: frequency of known mutations, identification of 17 novel mutations and in vitro expression of missense mutations","volume":"109","author":"Beesley","year":"2001","journal-title":"Hum Genet"},{"key":"B39","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3906\/sag-1411-160","article-title":"Evaluation and identification of IDUA gene mutations in Turkish patients with mucopolysaccharidosis type I","volume":"46","author":"At\u00e7eken","year":"2016","journal-title":"Turk J Med Sci"},{"key":"B40","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/8904_2014_395","article-title":"Long-term functional outcomes of children with hurler syndrome treated with unrelated umbilical cord blood transplantation","volume":"20","author":"Coletti","year":"2015","journal-title":"JIMD Rep"},{"key":"B41","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/humu.9051","article-title":"Molecular analysis of 30 mucopolysaccharidosis type I patients: evaluation of the mutational spectrum in Italian population and identification of 13 novel mutations","volume":"20","author":"Venturi","year":"2002","journal-title":"Hum Mutat"},{"key":"B42","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/ajmg.a.32812","article-title":"Mucopolysaccharidosis type I in 21 Czech and Slovak patients: mutation analysis suggests a functional importance of C-terminus of the IDUA protein","author":"Vazna","year":"2009","journal-title":"Am J Med Genet A"},{"key":"B43","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12881-016-0319-x","article-title":"Report of 5 novel mutations of the \u03b1-L-iduronidase gene and comparison of Korean mutations in relation with those of Japan or China in patients with mucopolysaccharidosis I","volume":"17","author":"Kwak","year":"2016","journal-title":"BMC Med Genet"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1007\/s10545-005-0197-4","article-title":"Mucopolysaccharidosis I: alpha-L-iduronidase mutations in three Tunisian families","volume":"28","author":"Laradi","year":"2005","journal-title":"J Inherit Metab Dis"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.arcped.2007.06.018","article-title":"[Mucopolysaccharidosis type I: identification of alpha-L-iduronidase mutations in Tunisian families]","volume":"14","author":"Chkioua","year":"2007","journal-title":"Arch Pediatr"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1376053\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T05:01:43Z","timestamp":1721019703000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1376053\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,15]]},"references-count":45,"alternative-id":["10.3389\/fped.2024.1376053"],"URL":"https:\/\/doi.org\/10.3389\/fped.2024.1376053","relation":{},"ISSN":["2296-2360"],"issn-type":[{"type":"electronic","value":"2296-2360"}],"subject":[],"published":{"date-parts":[[2024,7,15]]},"article-number":"1376053"}}